SEC Form 4 · accession 0000899243-18-025562
ARVINAS, INC. · ARVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Taylor
Officer — Senior Vice President, Biology
Period of report
Sep 26, 2018
Accepted (ET)
Sep 28, 2018 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001655759
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.00 | Sep 26, 2018 | A | 23,390 | A | — | Sep 25, 2028 | Common Stock | 23,390 | 23,390 | D |
| Stock Option (right to buy)F2 | $16.00 | Sep 26, 2018 | A | 2,600 | A | — | Sep 25, 2028 | Common Stock | 2,600 | 2,600 | D |
| Stock Option (right to buy)F3 | $16.00 | Sep 26, 2018 | A | 30,660 | A | — | Sep 25, 2028 | Common Stock | 30,660 | 30,660 | D |
| Stock Option (right to buy)F4 | $16.00 | Sep 26, 2018 | A | 44,390 | A | — | Sep 25, 2028 | Common Stock | 44,390 | 44,390 | D |
Explanation of responses
- F1This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 1, 2017, with the remainder of the shares vesting in equal monthly installments following June 1, 2017 through June 1, 2020.
- F2This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.
- F3This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.
- F4This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.